{"prompt": "Patient: 68 M\nAttending: Dr. Miller\nProcedures: Ion Robotic Bronchoscopy (LUL/RML), EBUS, Tumor Destruction (LLL)\nFindings: 7.4 cm mass, 2.3 cm nodule, obstructing tumor LLL.\nComplications: None.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Al-Fayed\n\nINDICATION FOR OPERATION\n68-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11L, 4L, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11L, 4L, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, iced saline, and topical epinephrine.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11L, 4L, 7 (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n68-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Patient: 75 M\nAttending: Dr. Miller\nProcedures: Ion Robotic Bronchoscopy (RLL/LUL), EBUS, Tumor Destruction (RML)\nFindings: 5.5 cm mass, 2.1 cm nodule, obstructing tumor RML.\nComplications: None.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\n75-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RML lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RLL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RLL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RLL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RLL, LUL, and RML\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11L, 4L, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RML\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RLL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RML bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RML segments (RB4 and RB5), causing complete obstruction. RB6 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Superior Segment RB6, 5.5 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRLL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Anterior Segment LB3, 2.1 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11L, 4L, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RML)\nEndobronchial tumor within multiple RML segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB4 and RB5; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB4 and RB5):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB4 and RB5) remained 0% patent. RB6 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with application of cold saline and oxidized cellulose.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRLL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRLL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11L, 4L, 7 (cytology for each)\nRML BAL: Cell count, micro, cytology\nRML Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n75-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Complex bronchoscopy with Modifier 22. Robot nav to RUL and LUL. EBUS staging. Endobronchial destruction of tumor at RLL. Multiple biopsies and BALs. Time extended due to complexity.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Al-Fayed\n\nINDICATION FOR OPERATION\n65-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 2R, 4R, 7, 10R)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Jones\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 2R, 4R, 7, 10R.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, iced saline, and topical epinephrine.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 2R, 4R, 7, 10R (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n65-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Complex bronchoscopy with Modifier 22. Robot nav to RUL and LUL. EBUS staging. Endobronchial destruction of tumor at RLL. Multiple biopsies and BALs. Time extended due to complexity.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\n62-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11Ri, 11Rs, 4R, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Harken\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11Ri, 11Rs, 4R, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with application of cold saline and oxidized cellulose.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11Ri, 11Rs, 4R, 7 (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n62-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Please generate an IP operative report for a 68 year old female. We performed a Robotic Navigational Bronchoscopy on a 6.2 cm mass in the RUL and a 1.8 cm nodule in the LUL. We also did EBUS staging and debulked a tumor in the RLL using Cryo and APC.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Al-Fayed\n\nINDICATION FOR OPERATION\n68-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11Ri, 11Rs, 4R, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Ingraham\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11Ri, 11Rs, 4R, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, iced saline, and topical epinephrine.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11Ri, 11Rs, 4R, 7 (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n68-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Pt 84 F. Indication: Mass LUL, nodule RML, LLL atelectasis. Done: Ion bx x2 targets, EBUS, and tumor destruction LLL for obstruction. Bleeding controlled. Samples sent.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Rossi\n\nINDICATION FOR OPERATION\n84-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 7, 4R, 4L, 11L)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Harken\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 7, 4R, 4L, 11L.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 7, 4R, 4L, 11L (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n84-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Pt 75 F. Indication: Mass LUL, nodule RML, LLL atelectasis. Done: Ion bx x2 targets, EBUS, and tumor destruction LLL for obstruction. Bleeding controlled. Samples sent.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Al-Fayed\n\nINDICATION FOR OPERATION\n75-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 2R, 4R, 7, 10R)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Jones\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 2R, 4R, 7, 10R.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, iced saline, and topical epinephrine.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 2R, 4R, 7, 10R (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n75-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Patient: 68 F\nAttending: Dr. Jones\nProcedures: Ion Robotic Bronchoscopy (RLL/LUL), EBUS, Tumor Destruction (RML)\nFindings: 5.5 cm mass, 2.1 cm nodule, obstructing tumor RML.\nComplications: None.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\n68-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RML lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RLL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RLL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RLL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RLL, LUL, and RML\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11L, 4L, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RML\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RLL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Jones\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RML bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RML segments (RB4 and RB5), causing complete obstruction. RB6 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Superior Segment RB6, 5.5 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRLL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Anterior Segment LB3, 2.1 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11L, 4L, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RML)\nEndobronchial tumor within multiple RML segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB4 and RB5; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB4 and RB5):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB4 and RB5) remained 0% patent. RB6 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with application of cold saline and oxidized cellulose.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRLL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRLL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11L, 4L, 7 (cytology for each)\nRML BAL: Cell count, micro, cytology\nRML Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n68-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Complex bronchoscopy with Modifier 22. Robot nav to LUL and RML. EBUS staging. Endobronchial destruction of tumor at LLL. Multiple biopsies and BALs. Time extended due to complexity.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Rossi\n\nINDICATION FOR OPERATION\n75-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11Ri, 11Rs, 4R, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11Ri, 11Rs, 4R, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with continuous suction and wedging of the scope.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11Ri, 11Rs, 4R, 7 (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n75-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "71yo F ion bronc. mass LUL, nodule RML. ebus stations Stations 11Ri, 11Rs, 4R, 7. also had to ablate tumor in LLL causing blockage. used cryo/apc. hemostasis ok.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\n71-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11Ri, 11Rs, 4R, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Jones\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11Ri, 11Rs, 4R, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with application of cold saline and oxidized cellulose.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11Ri, 11Rs, 4R, 7 (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n71-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Pt 65 M. Indication: Mass LUL, nodule RML, LLL atelectasis. Done: Ion bx x2 targets, EBUS, and tumor destruction LLL for obstruction. Bleeding controlled. Samples sent.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\n65-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11L, 4L, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Harken\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11L, 4L, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11L, 4L, 7 (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n65-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Complex bronchoscopy with Modifier 22. Robot nav to RUL and LUL. EBUS staging. Endobronchial destruction of tumor at RLL. Multiple biopsies and BALs. Time extended due to complexity.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Al-Fayed\n\nINDICATION FOR OPERATION\n73-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11Ri, 11Rs, 4R, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Harken\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11Ri, 11Rs, 4R, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, iced saline, and topical epinephrine.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11Ri, 11Rs, 4R, 7 (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n73-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Pt 62 M. Indication: Mass RUL, nodule LUL, RLL atelectasis. Done: Ion bx x2 targets, EBUS, and tumor destruction RLL for obstruction. Bleeding controlled. Samples sent.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\n62-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11L, 4L, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Harken\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11L, 4L, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, iced saline, and topical epinephrine.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11L, 4L, 7 (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n62-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Please generate an IP operative report for a 79 year old female. We performed a Robotic Navigational Bronchoscopy on a 7.4 cm mass in the LUL and a 2.3 cm nodule in the RML. We also did EBUS staging and debulked a tumor in the LLL using Cryo and APC.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Al-Fayed\n\nINDICATION FOR OPERATION\n79-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 2R, 4R, 7, 10R)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 2R, 4R, 7, 10R.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with application of cold saline and oxidized cellulose.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 2R, 4R, 7, 10R (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n79-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "84yo M ion bronc. mass LUL, nodule RML. ebus stations Stations 2R, 4R, 7, 10R. also had to ablate tumor in LLL causing blockage. used cryo/apc. hemostasis ok.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\n84-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 2R, 4R, 7, 10R)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Jones\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 2R, 4R, 7, 10R.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, iced saline, and topical epinephrine.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 2R, 4R, 7, 10R (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n84-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "79yo F ion bronc. mass LUL, nodule RML. ebus stations Stations 11L, 4L, 7. also had to ablate tumor in LLL causing blockage. used cryo/apc. hemostasis ok.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\n79-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11L, 4L, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11L, 4L, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with continuous suction and wedging of the scope.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11L, 4L, 7 (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n79-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Pt 71 M. Indication: Mass RLL, nodule LUL, RML atelectasis. Done: Ion bx x2 targets, EBUS, and tumor destruction RML for obstruction. Bleeding controlled. Samples sent.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Al-Fayed\n\nINDICATION FOR OPERATION\n71-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RML lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RLL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RLL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RLL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RLL, LUL, and RML\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 2R, 4R, 7, 10R)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RML\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RLL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Ingraham\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RML bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RML segments (RB4 and RB5), causing complete obstruction. RB6 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Superior Segment RB6, 5.5 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRLL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Anterior Segment LB3, 2.1 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 2R, 4R, 7, 10R.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RML)\nEndobronchial tumor within multiple RML segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB4 and RB5; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB4 and RB5):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB4 and RB5) remained 0% patent. RB6 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with application of cold saline and oxidized cellulose.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRLL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRLL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 2R, 4R, 7, 10R (cytology for each)\nRML BAL: Cell count, micro, cytology\nRML Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n71-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Patient: 73 M\nAttending: Dr. Miller\nProcedures: Ion Robotic Bronchoscopy (RUL/LUL), EBUS, Tumor Destruction (RLL)\nFindings: 6.2 cm mass, 1.8 cm nodule, obstructing tumor RLL.\nComplications: None.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\n73-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 7, 4R, 4L, 11L)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 7, 4R, 4L, 11L.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with continuous suction and wedging of the scope.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 7, 4R, 4L, 11L (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n73-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "75yo M ion bronc. mass RUL, nodule LUL. ebus stations Stations 11L, 4L, 7. also had to ablate tumor in RLL causing blockage. used cryo/apc. hemostasis ok.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\n75-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11L, 4L, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11L, 4L, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with application of cold saline and oxidized cellulose.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11L, 4L, 7 (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n75-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Complex bronchoscopy with Modifier 22. Robot nav to RUL and LUL. EBUS staging. Endobronchial destruction of tumor at RLL. Multiple biopsies and BALs. Time extended due to complexity.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Rossi\n\nINDICATION FOR OPERATION\n82-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 2R, 4R, 7, 10R)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Harken\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 2R, 4R, 7, 10R.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 2R, 4R, 7, 10R (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n82-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Please generate an IP operative report for a 82 year old female. We performed a Robotic Navigational Bronchoscopy on a 6.2 cm mass in the RUL and a 1.8 cm nodule in the LUL. We also did EBUS staging and debulked a tumor in the RLL using Cryo and APC.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Al-Fayed\n\nINDICATION FOR OPERATION\n82-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11L, 4L, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11L, 4L, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, iced saline, and topical epinephrine.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11L, 4L, 7 (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n82-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Patient: 82 M\nAttending: Dr. Harken\nProcedures: Ion Robotic Bronchoscopy (RLL/LUL), EBUS, Tumor Destruction (RML)\nFindings: 5.5 cm mass, 2.1 cm nodule, obstructing tumor RML.\nComplications: None.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\n82-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RML lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RLL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RLL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RLL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RLL, LUL, and RML\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 2R, 4R, 7, 10R)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RML\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RLL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Harken\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RML bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RML segments (RB4 and RB5), causing complete obstruction. RB6 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Superior Segment RB6, 5.5 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRLL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Anterior Segment LB3, 2.1 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 2R, 4R, 7, 10R.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RML)\nEndobronchial tumor within multiple RML segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB4 and RB5; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB4 and RB5):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB4 and RB5) remained 0% patent. RB6 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with application of cold saline and oxidized cellulose.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRLL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRLL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 2R, 4R, 7, 10R (cytology for each)\nRML BAL: Cell count, micro, cytology\nRML Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n82-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Complex bronchoscopy with Modifier 22. Robot nav to LUL and RML. EBUS staging. Endobronchial destruction of tumor at LLL. Multiple biopsies and BALs. Time extended due to complexity.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\n84-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11L, 4L, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Harken\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11L, 4L, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with continuous suction and wedging of the scope.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11L, 4L, 7 (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n84-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Please generate an IP operative report for a 73 year old female. We performed a Robotic Navigational Bronchoscopy on a 7.4 cm mass in the LUL and a 2.3 cm nodule in the RML. We also did EBUS staging and debulked a tumor in the LLL using Cryo and APC.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\n73-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 2R, 4R, 7, 10R)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Ingraham\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 2R, 4R, 7, 10R.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with continuous suction and wedging of the scope.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 2R, 4R, 7, 10R (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n73-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Please generate an IP operative report for a 84 year old female. We performed a Robotic Navigational Bronchoscopy on a 5.5 cm mass in the RLL and a 2.1 cm nodule in the LUL. We also did EBUS staging and debulked a tumor in the RML using Cryo and APC.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Al-Fayed\n\nINDICATION FOR OPERATION\n84-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RML lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RLL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RLL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RLL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RLL, LUL, and RML\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11L, 4L, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RML\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RLL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RML bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RML segments (RB4 and RB5), causing complete obstruction. RB6 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Superior Segment RB6, 5.5 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRLL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Anterior Segment LB3, 2.1 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11L, 4L, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RML)\nEndobronchial tumor within multiple RML segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB4 and RB5; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB4 and RB5):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB4 and RB5) remained 0% patent. RB6 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRLL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRLL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11L, 4L, 7 (cytology for each)\nRML BAL: Cell count, micro, cytology\nRML Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n84-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "79yo M ion bronc. mass LUL, nodule RML. ebus stations Stations 7, 4R, 4L, 11L. also had to ablate tumor in LLL causing blockage. used cryo/apc. hemostasis ok.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\n79-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 7, 4R, 4L, 11L)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 7, 4R, 4L, 11L.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with continuous suction and wedging of the scope.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 7, 4R, 4L, 11L (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n79-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Complex bronchoscopy with Modifier 22. Robot nav to RUL and LUL. EBUS staging. Endobronchial destruction of tumor at RLL. Multiple biopsies and BALs. Time extended due to complexity.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\n84-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11L, 4L, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Ingraham\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11L, 4L, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with application of cold saline and oxidized cellulose.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11L, 4L, 7 (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n84-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Please generate an IP operative report for a 71 year old male. We performed a Robotic Navigational Bronchoscopy on a 6.2 cm mass in the RUL and a 1.8 cm nodule in the LUL. We also did EBUS staging and debulked a tumor in the RLL using Cryo and APC.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\n71-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 2R, 4R, 7, 10R)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 2R, 4R, 7, 10R.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with continuous suction and wedging of the scope.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 2R, 4R, 7, 10R (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n71-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Patient: 75 M\nAttending: Dr. Miller\nProcedures: Ion Robotic Bronchoscopy (RLL/LUL), EBUS, Tumor Destruction (RML)\nFindings: 5.5 cm mass, 2.1 cm nodule, obstructing tumor RML.\nComplications: None.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Rossi\n\nINDICATION FOR OPERATION\n75-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RML lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RLL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RLL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RLL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RLL, LUL, and RML\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11L, 4L, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RML\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RLL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RML bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RML segments (RB4 and RB5), causing complete obstruction. RB6 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Superior Segment RB6, 5.5 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRLL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Anterior Segment LB3, 2.1 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11L, 4L, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RML)\nEndobronchial tumor within multiple RML segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB4 and RB5; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB4 and RB5):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB4 and RB5) remained 0% patent. RB6 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, iced saline, and topical epinephrine.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRLL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRLL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11L, 4L, 7 (cytology for each)\nRML BAL: Cell count, micro, cytology\nRML Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n75-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Patient: 79 M\nAttending: Dr. Harken\nProcedures: Ion Robotic Bronchoscopy (LUL/RML), EBUS, Tumor Destruction (LLL)\nFindings: 7.4 cm mass, 2.3 cm nodule, obstructing tumor LLL.\nComplications: None.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Rossi\n\nINDICATION FOR OPERATION\n79-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11L, 4L, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Harken\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11L, 4L, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with application of cold saline and oxidized cellulose.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11L, 4L, 7 (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n79-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Pt 73 M. Indication: Mass LUL, nodule RML, LLL atelectasis. Done: Ion bx x2 targets, EBUS, and tumor destruction LLL for obstruction. Bleeding controlled. Samples sent.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Al-Fayed\n\nINDICATION FOR OPERATION\n73-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11Ri, 11Rs, 4R, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11Ri, 11Rs, 4R, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with continuous suction and wedging of the scope.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11Ri, 11Rs, 4R, 7 (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n73-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Pt 73 F. Indication: Mass RLL, nodule LUL, RML atelectasis. Done: Ion bx x2 targets, EBUS, and tumor destruction RML for obstruction. Bleeding controlled. Samples sent.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Al-Fayed\n\nINDICATION FOR OPERATION\n73-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RML lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RLL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RLL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RLL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RLL, LUL, and RML\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 7, 4R, 4L, 11L)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RML\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RLL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Jones\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RML bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RML segments (RB4 and RB5), causing complete obstruction. RB6 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Superior Segment RB6, 5.5 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRLL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Anterior Segment LB3, 2.1 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 7, 4R, 4L, 11L.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RML)\nEndobronchial tumor within multiple RML segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB4 and RB5; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB4 and RB5):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB4 and RB5) remained 0% patent. RB6 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRLL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRLL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 7, 4R, 4L, 11L (cytology for each)\nRML BAL: Cell count, micro, cytology\nRML Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n73-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Please generate an IP operative report for a 68 year old male. We performed a Robotic Navigational Bronchoscopy on a 7.4 cm mass in the LUL and a 2.3 cm nodule in the RML. We also did EBUS staging and debulked a tumor in the LLL using Cryo and APC.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\n68-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11L, 4L, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Jones\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11L, 4L, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with application of cold saline and oxidized cellulose.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11L, 4L, 7 (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n68-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "73yo M ion bronc. mass RLL, nodule LUL. ebus stations Stations 11L, 4L, 7. also had to ablate tumor in RML causing blockage. used cryo/apc. hemostasis ok.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Rossi\n\nINDICATION FOR OPERATION\n73-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RML lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RLL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RLL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RLL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RLL, LUL, and RML\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11L, 4L, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RML\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RLL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Jones\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RML bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RML segments (RB4 and RB5), causing complete obstruction. RB6 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Superior Segment RB6, 5.5 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRLL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Anterior Segment LB3, 2.1 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11L, 4L, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RML)\nEndobronchial tumor within multiple RML segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB4 and RB5; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB4 and RB5):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB4 and RB5) remained 0% patent. RB6 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRLL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRLL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11L, 4L, 7 (cytology for each)\nRML BAL: Cell count, micro, cytology\nRML Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n73-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "62yo M ion bronc. mass RUL, nodule LUL. ebus stations Stations 2R, 4R, 7, 10R. also had to ablate tumor in RLL causing blockage. used cryo/apc. hemostasis ok.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\n62-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 2R, 4R, 7, 10R)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Ingraham\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 2R, 4R, 7, 10R.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 2R, 4R, 7, 10R (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n62-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Please generate an IP operative report for a 84 year old male. We performed a Robotic Navigational Bronchoscopy on a 6.2 cm mass in the RUL and a 1.8 cm nodule in the LUL. We also did EBUS staging and debulked a tumor in the RLL using Cryo and APC.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\n84-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 7, 4R, 4L, 11L)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Jones\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 7, 4R, 4L, 11L.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with application of cold saline and oxidized cellulose.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 7, 4R, 4L, 11L (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n84-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "84yo F ion bronc. mass LUL, nodule RML. ebus stations Stations 7, 4R, 4L, 11L. also had to ablate tumor in LLL causing blockage. used cryo/apc. hemostasis ok.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\n84-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 7, 4R, 4L, 11L)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Jones\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 7, 4R, 4L, 11L.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, iced saline, and topical epinephrine.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 7, 4R, 4L, 11L (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n84-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Pt 82 F. Indication: Mass RUL, nodule LUL, RLL atelectasis. Done: Ion bx x2 targets, EBUS, and tumor destruction RLL for obstruction. Bleeding controlled. Samples sent.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\n82-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 7, 4R, 4L, 11L)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Harken\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 7, 4R, 4L, 11L.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with continuous suction and wedging of the scope.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 7, 4R, 4L, 11L (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n82-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Please generate an IP operative report for a 82 year old male. We performed a Robotic Navigational Bronchoscopy on a 6.2 cm mass in the RUL and a 1.8 cm nodule in the LUL. We also did EBUS staging and debulked a tumor in the RLL using Cryo and APC.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\n82-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 7, 4R, 4L, 11L)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 7, 4R, 4L, 11L.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 7, 4R, 4L, 11L (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n82-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Pt 68 F. Indication: Mass LUL, nodule RML, LLL atelectasis. Done: Ion bx x2 targets, EBUS, and tumor destruction LLL for obstruction. Bleeding controlled. Samples sent.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\n68-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 7, 4R, 4L, 11L)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Ingraham\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 7, 4R, 4L, 11L.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 7, 4R, 4L, 11L (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n68-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Pt 75 F. Indication: Mass RLL, nodule LUL, RML atelectasis. Done: Ion bx x2 targets, EBUS, and tumor destruction RML for obstruction. Bleeding controlled. Samples sent.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Al-Fayed\n\nINDICATION FOR OPERATION\n75-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RML lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RLL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RLL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RLL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RLL, LUL, and RML\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11L, 4L, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RML\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RLL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Ingraham\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RML bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RML segments (RB4 and RB5), causing complete obstruction. RB6 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Superior Segment RB6, 5.5 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRLL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Anterior Segment LB3, 2.1 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11L, 4L, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RML)\nEndobronchial tumor within multiple RML segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB4 and RB5; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB4 and RB5):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB4 and RB5) remained 0% patent. RB6 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRLL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRLL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11L, 4L, 7 (cytology for each)\nRML BAL: Cell count, micro, cytology\nRML Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n75-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Patient: 84 F\nAttending: Dr. Miller\nProcedures: Ion Robotic Bronchoscopy (LUL/RML), EBUS, Tumor Destruction (LLL)\nFindings: 7.4 cm mass, 2.3 cm nodule, obstructing tumor LLL.\nComplications: None.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Al-Fayed\n\nINDICATION FOR OPERATION\n84-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11Ri, 11Rs, 4R, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11Ri, 11Rs, 4R, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with application of cold saline and oxidized cellulose.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11Ri, 11Rs, 4R, 7 (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n84-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Complex bronchoscopy with Modifier 22. Robot nav to RUL and LUL. EBUS staging. Endobronchial destruction of tumor at RLL. Multiple biopsies and BALs. Time extended due to complexity.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\n84-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11Ri, 11Rs, 4R, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Harken\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11Ri, 11Rs, 4R, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11Ri, 11Rs, 4R, 7 (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n84-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "68yo F ion bronc. mass RUL, nodule LUL. ebus stations Stations 2R, 4R, 7, 10R. also had to ablate tumor in RLL causing blockage. used cryo/apc. hemostasis ok.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\n68-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 2R, 4R, 7, 10R)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 2R, 4R, 7, 10R.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with application of cold saline and oxidized cellulose.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 2R, 4R, 7, 10R (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n68-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Patient: 84 M\nAttending: Dr. Harken\nProcedures: Ion Robotic Bronchoscopy (LUL/RML), EBUS, Tumor Destruction (LLL)\nFindings: 7.4 cm mass, 2.3 cm nodule, obstructing tumor LLL.\nComplications: None.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\n84-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 7, 4R, 4L, 11L)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Harken\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 7, 4R, 4L, 11L.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with continuous suction and wedging of the scope.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 7, 4R, 4L, 11L (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n84-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Patient: 73 M\nAttending: Dr. Harken\nProcedures: Ion Robotic Bronchoscopy (RLL/LUL), EBUS, Tumor Destruction (RML)\nFindings: 5.5 cm mass, 2.1 cm nodule, obstructing tumor RML.\nComplications: None.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\n73-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RML lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RLL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RLL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RLL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RLL, LUL, and RML\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11L, 4L, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RML\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RLL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Harken\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RML bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RML segments (RB4 and RB5), causing complete obstruction. RB6 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Superior Segment RB6, 5.5 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRLL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Anterior Segment LB3, 2.1 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11L, 4L, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RML)\nEndobronchial tumor within multiple RML segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB4 and RB5; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB4 and RB5):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB4 and RB5) remained 0% patent. RB6 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with application of cold saline and oxidized cellulose.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRLL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRLL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11L, 4L, 7 (cytology for each)\nRML BAL: Cell count, micro, cytology\nRML Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n73-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Pt 82 F. Indication: Mass RLL, nodule LUL, RML atelectasis. Done: Ion bx x2 targets, EBUS, and tumor destruction RML for obstruction. Bleeding controlled. Samples sent.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\n82-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RML lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RLL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RLL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RLL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RLL, LUL, and RML\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 7, 4R, 4L, 11L)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RML\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RLL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Ingraham\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RML bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RML segments (RB4 and RB5), causing complete obstruction. RB6 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Superior Segment RB6, 5.5 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRLL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Anterior Segment LB3, 2.1 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 7, 4R, 4L, 11L.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RML)\nEndobronchial tumor within multiple RML segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB4 and RB5; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB4 and RB5):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB4 and RB5) remained 0% patent. RB6 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, iced saline, and topical epinephrine.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRLL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRLL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 7, 4R, 4L, 11L (cytology for each)\nRML BAL: Cell count, micro, cytology\nRML Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n82-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Please generate an IP operative report for a 68 year old female. We performed a Robotic Navigational Bronchoscopy on a 7.4 cm mass in the LUL and a 2.3 cm nodule in the RML. We also did EBUS staging and debulked a tumor in the LLL using Cryo and APC.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\n68-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 7, 4R, 4L, 11L)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Jones\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 7, 4R, 4L, 11L.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with application of cold saline and oxidized cellulose.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 7, 4R, 4L, 11L (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n68-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Please generate an IP operative report for a 68 year old male. We performed a Robotic Navigational Bronchoscopy on a 5.5 cm mass in the RLL and a 2.1 cm nodule in the LUL. We also did EBUS staging and debulked a tumor in the RML using Cryo and APC.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\n68-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RML lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RLL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RLL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RLL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RLL, LUL, and RML\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 7, 4R, 4L, 11L)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RML\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RLL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RML bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RML segments (RB4 and RB5), causing complete obstruction. RB6 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Superior Segment RB6, 5.5 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRLL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Anterior Segment LB3, 2.1 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 7, 4R, 4L, 11L.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RML)\nEndobronchial tumor within multiple RML segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB4 and RB5; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB4 and RB5):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB4 and RB5) remained 0% patent. RB6 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with application of cold saline and oxidized cellulose.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRLL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRLL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 7, 4R, 4L, 11L (cytology for each)\nRML BAL: Cell count, micro, cytology\nRML Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n68-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Complex bronchoscopy with Modifier 22. Robot nav to LUL and RML. EBUS staging. Endobronchial destruction of tumor at LLL. Multiple biopsies and BALs. Time extended due to complexity.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\n73-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11L, 4L, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Jones\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11L, 4L, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, iced saline, and topical epinephrine.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11L, 4L, 7 (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n73-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Patient: 84 M\nAttending: Dr. Miller\nProcedures: Ion Robotic Bronchoscopy (RUL/LUL), EBUS, Tumor Destruction (RLL)\nFindings: 6.2 cm mass, 1.8 cm nodule, obstructing tumor RLL.\nComplications: None.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Rossi\n\nINDICATION FOR OPERATION\n84-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11Ri, 11Rs, 4R, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11Ri, 11Rs, 4R, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with application of cold saline and oxidized cellulose.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11Ri, 11Rs, 4R, 7 (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n84-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Complex bronchoscopy with Modifier 22. Robot nav to RLL and LUL. EBUS staging. Endobronchial destruction of tumor at RML. Multiple biopsies and BALs. Time extended due to complexity.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Rossi\n\nINDICATION FOR OPERATION\n82-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RML lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RLL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RLL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RLL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RLL, LUL, and RML\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11Ri, 11Rs, 4R, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RML\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RLL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Harken\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RML bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RML segments (RB4 and RB5), causing complete obstruction. RB6 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Superior Segment RB6, 5.5 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRLL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Anterior Segment LB3, 2.1 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11Ri, 11Rs, 4R, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RML)\nEndobronchial tumor within multiple RML segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB4 and RB5; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB4 and RB5):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB4 and RB5) remained 0% patent. RB6 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, iced saline, and topical epinephrine.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRLL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRLL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11Ri, 11Rs, 4R, 7 (cytology for each)\nRML BAL: Cell count, micro, cytology\nRML Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n82-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Patient: 62 F\nAttending: Dr. Jones\nProcedures: Ion Robotic Bronchoscopy (LUL/RML), EBUS, Tumor Destruction (LLL)\nFindings: 7.4 cm mass, 2.3 cm nodule, obstructing tumor LLL.\nComplications: None.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\n62-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11Ri, 11Rs, 4R, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Jones\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11Ri, 11Rs, 4R, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with continuous suction and wedging of the scope.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11Ri, 11Rs, 4R, 7 (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n62-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Patient: 71 M\nAttending: Dr. Jones\nProcedures: Ion Robotic Bronchoscopy (RUL/LUL), EBUS, Tumor Destruction (RLL)\nFindings: 6.2 cm mass, 1.8 cm nodule, obstructing tumor RLL.\nComplications: None.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\n71-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 7, 4R, 4L, 11L)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Jones\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 7, 4R, 4L, 11L.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with continuous suction and wedging of the scope.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 7, 4R, 4L, 11L (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n71-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Pt 82 F. Indication: Mass RUL, nodule LUL, RLL atelectasis. Done: Ion bx x2 targets, EBUS, and tumor destruction RLL for obstruction. Bleeding controlled. Samples sent.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\n82-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11L, 4L, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Ingraham\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11L, 4L, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with continuous suction and wedging of the scope.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11L, 4L, 7 (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n82-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Pt 84 M. Indication: Mass RLL, nodule LUL, RML atelectasis. Done: Ion bx x2 targets, EBUS, and tumor destruction RML for obstruction. Bleeding controlled. Samples sent.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\n84-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RML lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RLL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RLL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RLL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RLL, LUL, and RML\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 7, 4R, 4L, 11L)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RML\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RLL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Ingraham\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RML bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RML segments (RB4 and RB5), causing complete obstruction. RB6 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Superior Segment RB6, 5.5 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRLL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Anterior Segment LB3, 2.1 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 7, 4R, 4L, 11L.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RML)\nEndobronchial tumor within multiple RML segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB4 and RB5; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB4 and RB5):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB4 and RB5) remained 0% patent. RB6 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRLL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRLL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 7, 4R, 4L, 11L (cytology for each)\nRML BAL: Cell count, micro, cytology\nRML Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n84-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "71yo M ion bronc. mass RUL, nodule LUL. ebus stations Stations 7, 4R, 4L, 11L. also had to ablate tumor in RLL causing blockage. used cryo/apc. hemostasis ok.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\n71-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 7, 4R, 4L, 11L)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 7, 4R, 4L, 11L.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 7, 4R, 4L, 11L (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n71-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "62yo M ion bronc. mass RUL, nodule LUL. ebus stations Stations 11L, 4L, 7. also had to ablate tumor in RLL causing blockage. used cryo/apc. hemostasis ok.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\n62-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11L, 4L, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Ingraham\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11L, 4L, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with application of cold saline and oxidized cellulose.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11L, 4L, 7 (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n62-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Pt 75 F. Indication: Mass LUL, nodule RML, LLL atelectasis. Done: Ion bx x2 targets, EBUS, and tumor destruction LLL for obstruction. Bleeding controlled. Samples sent.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Al-Fayed\n\nINDICATION FOR OPERATION\n75-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 2R, 4R, 7, 10R)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Jones\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 2R, 4R, 7, 10R.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 2R, 4R, 7, 10R (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n75-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Complex bronchoscopy with Modifier 22. Robot nav to RUL and LUL. EBUS staging. Endobronchial destruction of tumor at RLL. Multiple biopsies and BALs. Time extended due to complexity.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Rossi\n\nINDICATION FOR OPERATION\n62-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 7, 4R, 4L, 11L)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Jones\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 7, 4R, 4L, 11L.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, iced saline, and topical epinephrine.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 7, 4R, 4L, 11L (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n62-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Patient: 79 F\nAttending: Dr. Ingraham\nProcedures: Ion Robotic Bronchoscopy (LUL/RML), EBUS, Tumor Destruction (LLL)\nFindings: 7.4 cm mass, 2.3 cm nodule, obstructing tumor LLL.\nComplications: None.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\n79-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 2R, 4R, 7, 10R)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Ingraham\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 2R, 4R, 7, 10R.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 2R, 4R, 7, 10R (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n79-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Please generate an IP operative report for a 65 year old male. We performed a Robotic Navigational Bronchoscopy on a 6.2 cm mass in the RUL and a 1.8 cm nodule in the LUL. We also did EBUS staging and debulked a tumor in the RLL using Cryo and APC.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Rossi\n\nINDICATION FOR OPERATION\n65-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 2R, 4R, 7, 10R)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Harken\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 2R, 4R, 7, 10R.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with application of cold saline and oxidized cellulose.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 2R, 4R, 7, 10R (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n65-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Complex bronchoscopy with Modifier 22. Robot nav to RLL and LUL. EBUS staging. Endobronchial destruction of tumor at RML. Multiple biopsies and BALs. Time extended due to complexity.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\n84-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RML lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RLL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RLL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RLL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RLL, LUL, and RML\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11Ri, 11Rs, 4R, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RML\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RLL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Harken\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RML bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RML segments (RB4 and RB5), causing complete obstruction. RB6 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Superior Segment RB6, 5.5 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRLL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Anterior Segment LB3, 2.1 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11Ri, 11Rs, 4R, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RML)\nEndobronchial tumor within multiple RML segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB4 and RB5; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB4 and RB5):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB4 and RB5) remained 0% patent. RB6 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with application of cold saline and oxidized cellulose.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRLL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRLL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11Ri, 11Rs, 4R, 7 (cytology for each)\nRML BAL: Cell count, micro, cytology\nRML Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n84-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Complex bronchoscopy with Modifier 22. Robot nav to RLL and LUL. EBUS staging. Endobronchial destruction of tumor at RML. Multiple biopsies and BALs. Time extended due to complexity.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\n68-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RML lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RLL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RLL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RLL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RLL, LUL, and RML\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 2R, 4R, 7, 10R)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RML\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RLL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Jones\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RML bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RML segments (RB4 and RB5), causing complete obstruction. RB6 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Superior Segment RB6, 5.5 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRLL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Anterior Segment LB3, 2.1 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 2R, 4R, 7, 10R.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RML)\nEndobronchial tumor within multiple RML segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB4 and RB5; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB4 and RB5):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB4 and RB5) remained 0% patent. RB6 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, iced saline, and topical epinephrine.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRLL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRLL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 2R, 4R, 7, 10R (cytology for each)\nRML BAL: Cell count, micro, cytology\nRML Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n68-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Please generate an IP operative report for a 65 year old male. We performed a Robotic Navigational Bronchoscopy on a 5.5 cm mass in the RLL and a 2.1 cm nodule in the LUL. We also did EBUS staging and debulked a tumor in the RML using Cryo and APC.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\n65-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RML lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RLL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RLL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RLL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RLL, LUL, and RML\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11L, 4L, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RML\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RLL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Harken\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RML bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RML segments (RB4 and RB5), causing complete obstruction. RB6 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Superior Segment RB6, 5.5 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRLL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Anterior Segment LB3, 2.1 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11L, 4L, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RML)\nEndobronchial tumor within multiple RML segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB4 and RB5; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB4 and RB5):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB4 and RB5) remained 0% patent. RB6 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRLL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRLL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11L, 4L, 7 (cytology for each)\nRML BAL: Cell count, micro, cytology\nRML Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n65-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Complex bronchoscopy with Modifier 22. Robot nav to RUL and LUL. EBUS staging. Endobronchial destruction of tumor at RLL. Multiple biopsies and BALs. Time extended due to complexity.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\n75-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11Ri, 11Rs, 4R, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Ingraham\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11Ri, 11Rs, 4R, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11Ri, 11Rs, 4R, 7 (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n75-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Pt 68 F. Indication: Mass RLL, nodule LUL, RML atelectasis. Done: Ion bx x2 targets, EBUS, and tumor destruction RML for obstruction. Bleeding controlled. Samples sent.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\n68-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RML lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RLL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RLL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RLL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RLL, LUL, and RML\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11Ri, 11Rs, 4R, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RML\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RLL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Ingraham\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RML bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RML segments (RB4 and RB5), causing complete obstruction. RB6 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Superior Segment RB6, 5.5 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRLL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Anterior Segment LB3, 2.1 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11Ri, 11Rs, 4R, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RML)\nEndobronchial tumor within multiple RML segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB4 and RB5; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB4 and RB5):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB4 and RB5) remained 0% patent. RB6 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRLL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRLL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11Ri, 11Rs, 4R, 7 (cytology for each)\nRML BAL: Cell count, micro, cytology\nRML Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n68-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Please generate an IP operative report for a 73 year old male. We performed a Robotic Navigational Bronchoscopy on a 7.4 cm mass in the LUL and a 2.3 cm nodule in the RML. We also did EBUS staging and debulked a tumor in the LLL using Cryo and APC.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Rossi\n\nINDICATION FOR OPERATION\n73-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 2R, 4R, 7, 10R)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Jones\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 2R, 4R, 7, 10R.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 2R, 4R, 7, 10R (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n73-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Patient: 73 F\nAttending: Dr. Miller\nProcedures: Ion Robotic Bronchoscopy (LUL/RML), EBUS, Tumor Destruction (LLL)\nFindings: 7.4 cm mass, 2.3 cm nodule, obstructing tumor LLL.\nComplications: None.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\n73-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 7, 4R, 4L, 11L)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 7, 4R, 4L, 11L.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with continuous suction and wedging of the scope.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 7, 4R, 4L, 11L (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n73-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Patient: 68 M\nAttending: Dr. Jones\nProcedures: Ion Robotic Bronchoscopy (LUL/RML), EBUS, Tumor Destruction (LLL)\nFindings: 7.4 cm mass, 2.3 cm nodule, obstructing tumor LLL.\nComplications: None.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\n68-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 7, 4R, 4L, 11L)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Jones\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 7, 4R, 4L, 11L.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with continuous suction and wedging of the scope.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 7, 4R, 4L, 11L (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n68-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Patient: 84 F\nAttending: Dr. Miller\nProcedures: Ion Robotic Bronchoscopy (LUL/RML), EBUS, Tumor Destruction (LLL)\nFindings: 7.4 cm mass, 2.3 cm nodule, obstructing tumor LLL.\nComplications: None.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\n84-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11L, 4L, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11L, 4L, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11L, 4L, 7 (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n84-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Complex bronchoscopy with Modifier 22. Robot nav to RLL and LUL. EBUS staging. Endobronchial destruction of tumor at RML. Multiple biopsies and BALs. Time extended due to complexity.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Smith\n\nINDICATION FOR OPERATION\n79-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RML lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RLL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RLL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RLL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RLL, LUL, and RML\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11L, 4L, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RML\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RLL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RML bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RML segments (RB4 and RB5), causing complete obstruction. RB6 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Superior Segment RB6, 5.5 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRLL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Anterior Segment LB3, 2.1 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11L, 4L, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RML)\nEndobronchial tumor within multiple RML segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB4 and RB5; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB4 and RB5):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB4 and RB5) remained 0% patent. RB6 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRLL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRLL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11L, 4L, 7 (cytology for each)\nRML BAL: Cell count, micro, cytology\nRML Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n79-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "84yo F ion bronc. mass RLL, nodule LUL. ebus stations Stations 7, 4R, 4L, 11L. also had to ablate tumor in RML causing blockage. used cryo/apc. hemostasis ok.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Rossi\n\nINDICATION FOR OPERATION\n84-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RML lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RLL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RLL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RLL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RLL, LUL, and RML\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 7, 4R, 4L, 11L)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RML\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RLL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Ingraham\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RML bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RML segments (RB4 and RB5), causing complete obstruction. RB6 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Superior Segment RB6, 5.5 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRLL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Anterior Segment LB3, 2.1 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 7, 4R, 4L, 11L.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RML)\nEndobronchial tumor within multiple RML segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB4 and RB5; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB4 and RB5):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB4 and RB5) remained 0% patent. RB6 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, iced saline, and topical epinephrine.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRLL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRLL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 7, 4R, 4L, 11L (cytology for each)\nRML BAL: Cell count, micro, cytology\nRML Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n84-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Patient: 71 M\nAttending: Dr. Miller\nProcedures: Ion Robotic Bronchoscopy (LUL/RML), EBUS, Tumor Destruction (LLL)\nFindings: 7.4 cm mass, 2.3 cm nodule, obstructing tumor LLL.\nComplications: None.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Rossi\n\nINDICATION FOR OPERATION\n71-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 7, 4R, 4L, 11L)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 7, 4R, 4L, 11L.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 7, 4R, 4L, 11L (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n71-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "68yo M ion bronc. mass RLL, nodule LUL. ebus stations Stations 11Ri, 11Rs, 4R, 7. also had to ablate tumor in RML causing blockage. used cryo/apc. hemostasis ok.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Bowers\n\nINDICATION FOR OPERATION\n68-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RML lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RLL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RLL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RLL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RLL, LUL, and RML\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11Ri, 11Rs, 4R, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RML\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RLL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Harken\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RML bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RML segments (RB4 and RB5), causing complete obstruction. RB6 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Superior Segment RB6, 5.5 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRLL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Anterior Segment LB3, 2.1 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11Ri, 11Rs, 4R, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RML)\nEndobronchial tumor within multiple RML segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB4 and RB5; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB4 and RB5):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB4 and RB5) remained 0% patent. RB6 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRLL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRLL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11Ri, 11Rs, 4R, 7 (cytology for each)\nRML BAL: Cell count, micro, cytology\nRML Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n68-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Please generate an IP operative report for a 79 year old female. We performed a Robotic Navigational Bronchoscopy on a 6.2 cm mass in the RUL and a 1.8 cm nodule in the LUL. We also did EBUS staging and debulked a tumor in the RLL using Cryo and APC.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\n79-year-old female who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 2R, 4R, 7, 10R)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Jones\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 2R, 4R, 7, 10R.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 2R, 4R, 7, 10R (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n79-year-old female who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Complex bronchoscopy with Modifier 22. Robot nav to LUL and RML. EBUS staging. Endobronchial destruction of tumor at LLL. Multiple biopsies and BALs. Time extended due to complexity.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\n79-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 2R, 4R, 7, 10R)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Harken\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 2R, 4R, 7, 10R.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 2R, 4R, 7, 10R (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n79-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Patient: 79 M\nAttending: Dr. Miller\nProcedures: Ion Robotic Bronchoscopy (LUL/RML), EBUS, Tumor Destruction (LLL)\nFindings: 7.4 cm mass, 2.3 cm nodule, obstructing tumor LLL.\nComplications: None.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\n79-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and LLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (LUL and RML)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of LUL and RML targets\nTransbronchial cryobiopsy (TBBX) of LUL and RML targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of LUL, RML, and LLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 2R, 4R, 7, 10R)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at LLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (LUL and RML), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nRight Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nLeft Lung: Moderate blood secretions and large clot burden, including complete obstruction of LLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the LLL segments (LB7/8 and LB6), causing complete obstruction. LB9-10 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical-Posterior Segment LB1/LB2, 7.4 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nLUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RML Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lateral Segment RB4, 2.3 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nRML BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 2R, 4R, 7, 10R.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (LLL)\nEndobronchial tumor within multiple LLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at LB7/8 and LB6; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (LB7/8 and LB6):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (LB7/8 and LB6) remained 0% patent. LB9-10 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with application of cold saline and oxidized cellulose.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nLUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nLUL BAL: Cell count, micro, cytology\nRML Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nRML BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 2R, 4R, 7, 10R (cytology for each)\nLLL BAL: Cell count, micro, cytology\nLLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n79-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Complex bronchoscopy with Modifier 22. Robot nav to RLL and LUL. EBUS staging. Endobronchial destruction of tumor at RML. Multiple biopsies and BALs. Time extended due to complexity.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Rossi\n\nINDICATION FOR OPERATION\n79-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RML lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RLL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RLL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RLL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RLL, LUL, and RML\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 11Ri, 11Rs, 4R, 7)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RML\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RLL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Miller\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RML bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RML segments (RB4 and RB5), causing complete obstruction. RB6 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RLL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Superior Segment RB6, 5.5 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRLL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Anterior Segment LB3, 2.1 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 11Ri, 11Rs, 4R, 7.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RML)\nEndobronchial tumor within multiple RML segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB4 and RB5; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB4 and RB5):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB4 and RB5) remained 0% patent. RB6 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with suction, cold saline, epinephrine 0.2mg, and APC.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRLL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRLL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 11Ri, 11Rs, 4R, 7 (cytology for each)\nRML BAL: Cell count, micro, cytology\nRML Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n79-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
{"prompt": "Please generate an IP operative report for a 62 year old male. We performed a Robotic Navigational Bronchoscopy on a 6.2 cm mass in the RUL and a 1.8 cm nodule in the LUL. We also did EBUS staging and debulked a tumor in the RLL using Cryo and APC.", "completion": "NOTE_ID: note_032\nDATE OF PROCEDURE: [Date] CC Referred Physician: Dr. Chen\n\nINDICATION FOR OPERATION\n62-year-old male who presents with lung mass, multiple lung nodules, mediastinal/hilar lymphadenopathy, and RLL lobar atelectasis.\n\nPREOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPOSTOPERATIVE DIAGNOSIS\nR91.8 Other nonspecific abnormal finding of lung field\n\nPROCEDURE\nNavigational Bronchoscopy (computer assisted) with Ion Robotic Bronchoscope (RUL and LUL)\nRadiology guidance for CT guided needle placement (Cios Spin)\n3D rendering with interpretation and reporting (Ion Planning Station)\nRadial EBUS for peripheral lesion\nFiducial marker placement\nTransbronchial needle aspiration (TBNA) of RUL and LUL targets\nTransbronchial cryobiopsy (TBBX) of RUL and LUL targets\nTransbronchial brushing and Mini-BAL\nBronchoalveolar lavage (BAL) of RUL, LUL, and RLL\nTherapeutic aspiration (initial episode) for clot/mucus clearance\nEBUS sampling 3 or more nodes (Stations 7, 4R, 4L, 11L)\nUltrasound Elastography (First and Additional Targets)\nDestruction of tumor (Cryotherapy and APC) at RLL\n31899 Unlisted Procedure (Trach Change with Mature Tract or Procedure NOS)\n\nMODIFIER 22 (INCREASED PROCEDURAL SERVICES)\nThis patient required Transbronchial Cryo biopsies at two different locations, Robotic Navigation to two different sites (RUL and LUL), CT-guided needle placement at two locations, multiple Bronchoalveolar lavages in three different locations, Brushings at multiple locations, and Radial EBUS performed at multiple locations. The patient required endobronchial biopsies at two discrete locations and endobronchial destruction of tumor by method other than excision at two discrete locations. The patient required ultrasound elastography evaluation of discrete lymph node sites, with the images/interpretation used for intraprocedural decision-making. This resulted in >100% increased work due to increased intensity, time, technical difficulty, severity of patient's condition, and physical/mental effort required.\n\nATTENDING: Dr. Ingraham\n\nANESTHESIA: General Anesthesia\nMONITORING: Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\nINSTRUMENTATION: Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope.\nESTIMATED BLOOD LOSS: Moderate\nCOMPLICATIONS: None\n\nPROCEDURE IN DETAIL\nA timeout was performed confirming the patient's name, procedure type, and procedure location. After the successful induction of anesthesia, anesthesia placed an ETT.\nVentilation Parameters: Mode: VCV; RR: 14; TV: 450; PEEP: 12; FiO2: 70%; Flow Rate: 10; Pmean: 17.\n\nInitial Airway Inspection\nThe Flexible Therapeutic Bronchoscope was advanced. Endobronchial topical lidocaine was applied to the main carina, right carina 1, and left carina 2.\n\nTrachea: Distal 1/3 normal with thin bloody secretions.\nLeft Lung: Bloody secretions and scattered mild blood clot burden within the airways. Normal anatomic branching to first subsegmental level. No endobronchial tumor or active bleeding source identified.\nRight Lung: Moderate blood secretions and large clot burden, including complete obstruction of RLL bronchus due to clot.\n\nFollowing therapeutic aspiration, endobronchial tumor was noted protruding from the RLL segments (RB6 and RB10), causing complete obstruction. RB7-9 segments appeared patent after clot removal.\n\nTherapeutic Aspiration: Successful aspiration was performed to clean out the distal trachea and bilateral mainstems from mucus, blood, and blood clots.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 RUL Mass\nA CT-based navigation plan was loaded and partial registration was completed. The Ion robotic catheter was advanced to 0.5 cm from the planned target (Apical Segment RB1, 6.2 cm lesion).\nrEBUS: Concentric pattern with continuous margin and absence of linear-discrete air bronchogram.\nCone-Beam CT (Cios Spin): A low dose spin was performed; 3D reconstruction and overlay confirmed tool-in-lesion.\n\nSampling:\nTBNA: 8 samples collected with 21G and 23G needles (Cytology, Flow, Cultures).\nCryobiopsy: 10 samples collected with 1.1 mm cryoprobe (6s freeze) (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Cytology).\nFiducial: One 0.8mm x 3mm soft tissue gold marker placed under fluoroscopy.\nROSE: TBNA showed atypical cells, large naked nuclei; cryo showed possible atypical histiocytes; not definitive for RCC.\nRUL BAL: Performed with 40 cc saline, 15 cc return.\n\nRobotic Navigational Bronchoscopy (Ion) \u2014 LUL Nodule\nPartial registration was repeated. The catheter was advanced to 0.5 cm from the target (Lingula LB4, 1.8 cm).\nrEBUS: Eccentric pattern with continuous margin.\nCone-Beam CT (Cios Spin): 3D reconstruction confirmed tool-in-lesion.\n\nSampling:\nTBNA: 7 samples collected with 21G and 23G needles (Cytology, Cultures).\nCryobiopsy: 6 samples collected with 1.1 mm cryoprobe (Pathology).\nBrushing: 1 sample (Cytology).\nMini-BAL: 10 cc instilled, 5 cc return (Micro/Cultures).\nFiducial: Attempted, but marker appeared to fall out and did not enter the nodule.\nROSE: Macrophages, lymphocytes, bronchial cells.\nLUL BAL: Performed with 60 cc saline, 60 cc return.\n\nPost-biopsy fluoroscopy was negative for pneumothorax bilaterally.\n\nEBUS Staging and Elastography\nThe EBUS scope was introduced. All lymph node stations were assessed; only those >=5 mm were sampled.\nLymph nodes sampled: Stations 7, 4R, 4L, 11L.\nElastography showed mixed Type 1 (soft/benign) and Type 2 (mixed soft/stiff) patterns across stations.\nROSE for EBUS: Adequate lymphocytes and histiocytes present in all samples.\n\nEndobronchial Tumor Management (RLL)\nEndobronchial tumor within multiple RLL segmental airways was friable and bled easily.\nBiopsy: Endobronchial cryobiopsy performed at RB6 and RB10; lesions successfully removed and sent for pathology.\nROSE: Atypical cells, large naked nuclei.\n\nTumor Destruction (RB6 and RB10):\nCryotherapy: 1.1mm probe used (8-12 sec) to debulk tumor.\nAPC: 1.5mm probe (forcedAPC, 0.5 LPM, Effect 2) applied for coagulation/devitalization.\n\nResults: Partial ablation achieved; hemostasis achieved (resolution of bleeding). However, airways (RB6 and RB10) remained 0% patent. RB7-9 airways were 100% patent after extraction of clot and nearby tumor.\nHemostasis: Nashville Grade 2 bleeding controlled with application of cold saline and oxidized cellulose.\n\nConclusion\nResidual secretions were suctioned. No active bleeding was seen. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\nRUL Mass: TBNA (cytology, flow, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cytology)\nRUL BAL: Cell count, micro, cytology\nLUL Nodule: TBNA (cytology, cultures), TBCBx (pathology), Brushing (cytology), Mini-BAL (cultures)\nLUL BAL: Cell count, micro, cytology\nEBUS TBNA: Stations 7, 4R, 4L, 11L (cytology for each)\nRLL BAL: Cell count, micro, cytology\nRLL Endobronchial Biopsy: Pathology\n\nIMPRESSION / PLAN\n62-year-old male who underwent bronchoscopy for lung mass biopsy, lung nodule biopsy, lymph node assessment, and endobronchial tumor destruction.\nObtain post-procedure CXR (ordered).\nInpatient primary team and IP consult team to follow up final results.\nIf discharged, follow up in IP clinic in 1-2 weeks.\nIf hemoptysis develops, recommend starting nebulized TXA.\n"}
